BEC, a novel enterotoxin of Clostridium perfringens found in human clinical isolates from acute gastroenteritis outbreaks
S Yonogi, S Matsuda, T Kawai, T Yoda… - Infection and …, 2014 - Am Soc Microbiol
Clostridium perfringens is a causative agent of food-borne gastroenteritis for which C.
perfringens enterotoxin (CPE) has been considered an essential factor. Recently, we …
perfringens enterotoxin (CPE) has been considered an essential factor. Recently, we …
Characterization of Clostridium perfringens strains isolated from Polish patients with suspected antibiotic-associated diarrhea.
P Obuch-Woszczatyński, M Łuczak… - Medical Science …, 2002 - medscimonit.com
BACKGROUND: The aim of our research was to investigate the role of enterotoxin-
producing anaerobic bacteria other than Clostridium difficile in the etiology of antibiotic …
producing anaerobic bacteria other than Clostridium difficile in the etiology of antibiotic …
A review of three cases of Clostridium aldenense bacteremia
OM Williams, J Brazier, V Peraino, EJC Goldstein - Anaerobe, 2010 - Elsevier
Three cases of Clostridium aldenense bacteremia are reported. C. aldenense is also
associated with intra-abdominal infections and closely resembles Clostridium …
associated with intra-abdominal infections and closely resembles Clostridium …
An update on the human and animal enteric pathogen Clostridium perfringens
Clostridium perfringens, a rapid-growing pathogen known to secrete an arsenal of> 20
virulent toxins, has been associated with intestinal diseases in both animals and humans …
virulent toxins, has been associated with intestinal diseases in both animals and humans …
Clostridium novyi, sordellii, and tetani: mechanisms of disease
DM Aronoff - Anaerobe, 2013 - Elsevier
Clostridia represent a diverse group of spore-forming gram positive anaerobes that include
several pathogenic species. In general, diseases caused by clostridia are a result of …
several pathogenic species. In general, diseases caused by clostridia are a result of …
[HTML][HTML] Clostridium perfringens and Escherichia coli bacteremia in a patient with acute obstructive suppurative cholangitis: a case report and review of the literature
P Zhang, N Jiang, L Xu, Z Shen, X Liu… - The American journal of …, 2022 - ncbi.nlm.nih.gov
Objective: Rare disease Background: Clostridium perfringens (CP), one of several clostridial
species gram-positive bacteria, is a major cause of animal necrosis enteritis and traumatic …
species gram-positive bacteria, is a major cause of animal necrosis enteritis and traumatic …
Extensive genome analysis identifies novel plasmid families in Clostridium perfringens
Globally, the anaerobic bacterium Clostridium perfringens causes severe disease in a wide
array of hosts; however, C. perfringens strains are also carried asymptomatically. Accessory …
array of hosts; however, C. perfringens strains are also carried asymptomatically. Accessory …
Skin and environmental contamination with vancomycin-resistant enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium …
AK Sethi, WN Al-Nassir, MM Nerandzic… - Infection Control & …, 2009 - cambridge.org
Background. Oral metronidazole has been recommended for treatment of mild-to-moderate
Clostridium difficile–associated disease (CDAD), in part because of concern that use of …
Clostridium difficile–associated disease (CDAD), in part because of concern that use of …
[HTML][HTML] Clostridium sporogenes bacteremia in an immunocompetent patient
W Abusnina, M Shehata, E Karem, Z Koc, E Khalil - IDCases, 2019 - Elsevier
Of the 200 Clostridium spp. known to exist, approximately 30 have been associated with
human disease. Commonly found in soil, marine sediment and mammalian intestinal tracts …
human disease. Commonly found in soil, marine sediment and mammalian intestinal tracts …
New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain
W Li, J Hu, L Li, M Zhang, Q Cui, Y Ma, H Su… - Frontiers in …, 2022 - frontiersin.org
Daptomycin (DAP), a last-resort antibiotic for treating Gram-positive bacterial infection, has
been widely used in the treatment of vancomycin-resistant enterococci (VRE). Resistance to …
been widely used in the treatment of vancomycin-resistant enterococci (VRE). Resistance to …